PepGen News
News
0
Ticker
PEPG
ISIN
US7133171055
PepGen Eulerpool News
PepGen Stock News
PepGen is being monitored by journalists and investors worldwide. We gather the latest PepGen news here.
- February 6·Benzinga
- December 8·Benzinga
- November 12·Benzinga
- November 12·Benzinga
- October 29·SeekingAlpha
- October 28·Benzinga
- October 7·SeekingAlpha
- September 26·Benzinga
- September 26·Yahoo
- September 25·Benzinga
- September 25·Benzinga
- September 25·Benzinga
- September 25·Benzinga
- September 24·Benzinga
- September 9·Benzinga
- August 7·Yahoo
- May 30·Yahoo
- May 30·Yahoo
- May 30·Yahoo
- May 29·Benzinga
PepGen Stock Press Releases
PepGen regularly publishes news on the company's website that are relevant for investors.
PepGen News 2026
This page contains all current news, analysis and press releases for PepGen stock (PEPG, ISIN: US7133171055). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at PepGen.
PepGen Stock
PepGen PepGen Inc., based in Cambridge, Massachusetts, is a biotechnology company focused on developing oligonucleotide therapies for neuromuscular and neurologic diseases. The company utilizes its enhanced delivery oligonucleotide (EDO) platform, which employs cell-penetrating peptides to enhance therapeutic delivery. Its lead candidates, PGN-EDO51 for Duchenne muscular dystrophy and PGN-EDODM1 for myotonic dystrophy type 1, are part of a pipeline targeting degenerative conditions. Listed on 6 May 2022, PepGen operates with a team of 56 employees.